Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.45 -0.04 (-8.73%)
At close: Oct 22, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Non-Current Debt (2021 - 2025)

Updated

Analysis

Pasithea Therapeutics (KTTA) Non-Current Debt (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 35.80 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 62.48 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 60.50 Bn
10 Pasithea Therapeutics 14.30 Mn -141.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -179,310.00
Sep 30, 2023 -133,335.00
Jun 30, 2023 -130,768.00
Mar 31, 2023 264,103.00
Dec 31, 2021 5.30 Mn
Sep 30, 2021 20.65 Mn
Mar 31, 2021 1.21 Mn
API Access

Pasithea Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=KTTA&period=max&api_key=YOUR_API_KEY